Table 1.
Relationships of the PIK3CA E545K mutation with the clinicopathological characteristics of the GBCs
Parameter | Category | No.of cases | PI3K E545K mutation status | ||
---|---|---|---|---|---|
No.of positive cases (%) | χ2 | P value | |||
Age | <60 | 60 | 3 (5 %) | 0.020 | 0.888 |
≥60 | 70 | 5 (7.14 %) | |||
Gender | Male | 61 | 3 (4.92 %) | 0.034 | 0.853 |
Female | 69 | 5 (7.25 %) | |||
Lymph node metastasis | Negative | 86 | 4 (4.65 %) | 0.373 | 0.541 |
Positive | 44 | 4 (9.09 %) | |||
TNM stage | II | 8 | 0 (0 %) | (a) | 0.352 |
III | 101 | 6 (5.94 %) | |||
IV | 21 | 2 (9.52 %) | |||
Margin status | R0 | 71 | 5 (7.04 %) | 0.009 | 0.924 |
R1 | 59 | 3 (5.08 %) | |||
Jaundice | Negative | 91 | 6 (6.59 %) | 0.000 | 1.000 |
Positive | 39 | 2 (5.13 %) |
(a) The TNM stage data did not meet the criterion for χ2 analysis, thus, we used a Spearman rank correlation analysis